Artificial intelligence is transforming healthcare, unleashing new investment opportunities. From cancer screening to drug discovery, AI promises to augment clinical decision-making and improve care. We’ll explore the surging ecosystem of medical AI innovations, from the emerging tech landscape to practical deployment. But what are the challenges facing real-world implementation? Which applications show the most promise? Join us as we investigate how artificial intelligence can change healthcare for the better while examining what it will take to do it well. Guests include: Bob Nelsen, Co-Founder and Managing Director at Arch Venture Partners Daphne Koller, Founder and CEO at insitro David Baker, Ph.D., 2024 Nobel Prize in Chemistry Laureate, Director at the Institute for Protein Design and Professor of Biochemistry at University of Washington Theresa Hajer, Partner and Managing Director of Venture Capital Research at Cambridge Associates Unseen Upside: Investments Beyond Their Returns is developed in partnership with PRX, an award-winning podcast media company. Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related